Home / Italy / CTI Biopharma Corp
CTI Biopharma Corp
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
163 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
November 30, 2012 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 26, 2012 | The Goldman Sachs Group, Inc. | 1.30% | still open |
| December 24, 2012 | The Goldman Sachs Group, Inc. | 1.24% | still open |
| December 21, 2012 | The Goldman Sachs Group, Inc. | 1.19% | still open |
| December 19, 2012 | The Goldman Sachs Group, Inc. | 0.95% | still open |
| December 18, 2012 | The Goldman Sachs Group, Inc. | 1.05% | still open |
| December 12, 2012 | The Goldman Sachs Group, Inc. | 1.15% | still open |
| December 10, 2012 | The Goldman Sachs Group, Inc. | 1.37% | still open |
| December 7, 2012 | The Goldman Sachs Group, Inc. | 1.54% | still open |
| December 6, 2012 | The Goldman Sachs Group, Inc. | 1.37% | still open |
| December 5, 2012 | The Goldman Sachs Group, Inc. | 1.42% | still open |
| December 4, 2012 | The Goldman Sachs Group, Inc. | 1.35% | still open |
| December 3, 2012 | The Goldman Sachs Group, Inc. | 0.97% | still open |
| November 30, 2012 | The Goldman Sachs Group, Inc. | 1.07% | still open |
Other companies sold short in Italy
- Saipem SPA 14.96% of the capital sold short
- Avio SPA 7.58% of the capital sold short
- DoVALUE SPA 5.99% of the capital sold short
- BFF Bank SPA 5.86% of the capital sold short
- Stellantis NV 5.13% of the capital sold short
- Nexi SPA 4.37% of the capital sold short
- Banca Ifis SPA 4.31% of the capital sold short
- Sanlorenzo SPA 3.30% of the capital sold short
- Moncler SPA 2.78% of the capital sold short
- Amplifon SPA 2.73% of the capital sold short
- Fincantieri SPA 2.71% of the capital sold short
- Trevi - Finanziaria Industriale SPA 2.59% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, CTI Biopharma Corp, source Consob, data as at June 14, 2017, https://www.quivad.com/action/cti-biopharma-corp?page=4